NANoREG D2.12 DR Framework and procedures for characterization and reporting of manufactured nanomaterials for regulatory use Acesse: https://www.rivm.nl/en/documenten/nanoreg-d212-dr-framework-and-procedures-for-characterization-and-reporting-of
NANoREG D2.12 DR Framework and procedures for characterization and reporting of manufactured nanomaterials for regulatory use
NANoREG D4 15 DR Protocol for inhalation exposure and choice of biological relevant endpoints
NANoREG D2 08 DR Protocols for exposure fate characterization in ecotoxicity and in vitro studies
NANoREG D5 01 DR Report on identification and setting of categorization read across and extra intrapolation criteria
NANoREG D5.07 SOP 19 Whole blood cell assay for cytokine production
https://www.rivm.nl/documenten/nanoreg-d507-sop-19-whole-blood-cell-assay-for-cytokine-production
NANoREG D4 03 DR Lung burden and particle detection and quantification in olfactory bulbs blood sub acute exposure
NANoREG D5.07 SOP 10 HEL11T005 HTS Comet Assay with and without FPG – 12 wells
